- Agency for Healthcare Research and Quality. Overview of the National (Nationwide) Inpatient Sample (NIS). https://hcup-us.ahrq.gov/nisoveriew.jsp. Accessed October 25, 2023.
- Bodla ZH, Hashmi M, Niaz F, et al. Independent predictors of mortality and 5-year trends in mortality and resource utilization in hospitalized patients with diffuse large B cell lymphoma. Proc (Bayl Univ Med Cent). 2024;37(1). doi:10.1080/08998280.2023.2267921.
- Tavakkoli M, Barta SK. 2024 Update: Advances in the risk stratification and management of large B-cell lymphoma. Am J Hematol. 2023;98(11):1791–1805. doi:10.1002/ajh.27075.
- Atak S, Serin S, Demirel N, et al. The obesity controversy: does it impact treatment response in diffuse large B-cell lymphoma? Int J Hematol Oncol Stem Cell Res. 2023;17(2):75–80. doi:10.18502/ijhoscr.v17i2.12643.
- Carson KR, Bartlett NL, McDonald JR, et al. Increased body mass index is associated with improved survival in United States veterans with diffuse large B-cell lymphoma. JCO. 2012;30(26):3217–3222. doi:10.1200/JCO.2011.39.2100.
- Geyer SM, Morton LM, Habermann TM, et al. Smoking, alcohol use, obesity, and overall survival from non-Hodgkin lymphoma: a population-based study. Cancer. 2010;116(12):2993–3000. doi:10.1002/cncr.25114.
- Fatakhova K, Patel P, Inayat F, et al. Trends in hospital admissions and mortality among inflammatory bowel disease patients with substance use disorder: a 10-year United States nationwide analysis. Proc (Bayl Univ Med Cent). 2023;36(4):427–433. doi:10.1080/08998280.2023.2204535.
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 37, 2024 - Issue 1
Original Research: Oncology
A valuable database for disease trends and treatment
Peter S. StackBaylor Scott and White Health Care System, Plano, Texas, USACorrespondence[email protected]
https://orcid.org/0009-0008-8810-6665
, MDhttps://orcid.org/0009-0008-8810-6665